Prenatal Starting Early Program mHealth
- Disease/Condition
- Pregnancy
- Drug/Device/Intervention
- StEP:Prenatal
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- NYU Langone Health
- Location
- New York, United States of America
- Phase
- N/A
- Start date
- Oct 23, 2023
- End date
- Apr 14, 2026
- Enrollment
- 300 participants
Daily servings of fruits (cup equivalents),Daily servings of whole grains (ounce equivalents),Daily servings of refined grains (ounce equivalents),Daily servings of dairy (total milk cup equivalents),Daily servings of vegetables (cup equivalents),Number of times 100% pure fruit juice consumed,Number of times sugar sweetened beverages (not including 100% fruit juice) consumed,Daily servings of protein foods (ounce equivalents),Healthy Eating Index (HEI)-2015 score,Daily servings of fruits (cup equivalents),Daily servings of whole grains (ounce equivalents),Daily servings of refined grains (ounce equivalents),Daily servings of dairy (total milk cup equivalents),Daily servings of vegetables (cup equivalents),Daily servings of protein foods (ounce equivalents),Number of times 100% pure fruit juice consumed,Number of times sugar sweetened beverages (not including 100% fruit juice) consumed,Healthy Eating Index (HEI)-2015 score,Total amount of screen time,Total amount of physical activity,Total amount of screen time,Total amount of physical activity
The purpose of this interventional trial is to test the efficacy of the remote delivery of
 the StEP:Prenatal intervention compared to standard prenatal care in pregnant individuals
 planning to receive prenatal and pediatric care at Bellevue Hospital. The primary aims are to
 determine the efficacy of the remotely delivered StEP:Prenatal intervention on diet,
 lifestyle behaviors, social determinants of health (SDoH), and pregnancy outcomes.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06087133
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06087133 through Pure Global AI's free database. This phase not specified trial is sponsored by NYU Langone Health and is currently Not yet recruiting. The study focuses on Pregnancy. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.